Jeremy R. Graff
President and Chief Development Officer · Allarity Therapeutics, Inc.
Individual
- 2024
- Oct 9, 2026
- 6
Other insiders active in the same sector
No other insider has filed at Jeremy R. Graff's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Eric Venker - $79.97M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
- Charles N. Mills - $74.80M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeremy R. Graff?
Jeremy R. Graff is a corporate insider, tracked as President and Chief Development Officer of Allarity Therapeutics, Inc. (ALLR). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeremy R. Graff submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
